Related Experiment Video
Updated: May 29, 2026
08:03
Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Glycosphingolipids and insulin resistance
Johannes M Aerts1, Rolf G Boot, Marco van Eijk
1Department of Medical Biochemistry, University of Amsterdam, The Netherlands. j.m.aerts@amc.uva.nl
Advances in Experimental Medicine and Biology
|September 13, 2011
Summary
Glycosphingolipids play a key role in insulin resistance, a condition linked to metabolic syndrome. Reducing glycosphingolipid production in animal models improved insulin resistance, suggesting therapeutic potential.
Area of Science:
- Biochemistry
- Cell Biology
- Metabolic Diseases
Background:
- Glycosphingolipids are essential structural components of the plasma membrane.
- Insulin resistance is a growing global health concern, underlying metabolic syndrome and associated diseases.
- The precise role of glycosphingolipids in insulin signaling is under investigation.
Purpose of the Study:
- To explore the proposed role of glycosphingolipids in insulin resistance.
- To evaluate the therapeutic potential of modulating glycosphingolipid biosynthesis.
Main Methods:
- Review of existing evidence on glycosphingolipids and insulin signaling.
- Analysis of findings from animal models with reduced glycosphingolipid biosynthesis.
Main Results:
- Evidence suggests an indirect but critical regulatory role for glycosphingolipids in insulin signaling.
- Pharmacological reduction of glycosphingolipid biosynthesis ameliorated insulin resistance in animal models.
- These reductions were well-tolerated, indicating potential safety.
Conclusions:
- Glycosphingolipids are implicated as critical regulators in insulin resistance.
- Targeting glycosphingolipid biosynthesis may offer a viable therapeutic strategy for metabolic syndrome and related conditions.
More Related Videos
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:23Dipeptidyl Peptidase 4 Inhibitors
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...